Dr. MacLean owns stock and/or holds stock options in WellPoint.
Systemic Lupus Erythematosus
A quality indicator set for systemic lupus erythematosus
Version of Record online: 26 FEB 2009
Copyright © 2009 by the American College of Rheumatology
Arthritis Care & Research
Volume 61, Issue 3, pages 370–377, 15 March 2009
How to Cite
Yazdany, J., Panopalis, P., Gillis, J. Z., Schmajuk, G., MacLean, C. H., Wofsy, D., Yelin, E. and Systemic Lupus Erythematosus Quality Indicators Project Expert Panels (2009), A quality indicator set for systemic lupus erythematosus. Arthritis & Rheumatism, 61: 370–377. doi: 10.1002/art.24356
- Issue online: 26 FEB 2009
- Version of Record online: 26 FEB 2009
- Manuscript Accepted: 4 DEC 2008
- Manuscript Received: 6 SEP 2008
- Arthritis Foundation
- American College of Rheumatology Research and Education Foundation
- National Institute of Arthritis and Musculoskeletal and Skin Diseases. Grant Number: P60-AR-053308
- Rosalind Russell Medical Research Center for Arthritis at the University of California, San Francisco
Additional Supporting Information may be found in the online version of this article.
|ART_24356_sm_AppendixAB.doc||98K||Appendix A: Members of the Systemic Lupus Erythematosus Quality Indicators Project Advisory Panel and the RAND/UCLA Appropriateness Method Expert Panel; Appendix B: Items Deleted from the Systemic Lupus Erythematosus Quality Indicator Set|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.